financetom
Business
financetom
/
Business
/
Palantir Technologies Q4 Adjusted Earnings, Revenue Increase; Sets Q1, 2025 Oulook -- Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Palantir Technologies Q4 Adjusted Earnings, Revenue Increase; Sets Q1, 2025 Oulook -- Shares Rise
Feb 3, 2025 1:41 PM

04:14 PM EST, 02/03/2025 (MT Newswires) -- Palantir Technologies ( PLTR ) reported Q4 adjusted earnings late Monday of $0.14 per share, up from $0.08 a year earlier.

Analysts surveyed by FactSet expected $0.11.

Revenue in the three months ended Dec. 31 rose to $827.5 million from $608.4 million a year earlier.

Analysts polled by FactSet expected $775.8 million.

The company expects Q1 revenue of $858 million to $862 million.

Analysts surveyed by FactSet expect $799.6 million.

The company expects full-year revenue between $3.74 billion to $3.76 billion.

Analysts polled by FactSet expect $3.50 billion.

Shares of the company jumped 15% in recent after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond
Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond
Oct 15, 2025
Second Acquisition in Three Months Builds Momentum NEW YORK--(BUSINESS WIRE)-- Real Chemistry, a leader in AI-driven insights and marketing communications for the healthcare industry, continues to strengthen its media capabilities by acquiring Spring & Bond. A digital media agency known for its omnichannel-first approach and data-driven solutions, Spring & Bond is focused exclusively on healthcare, working with leading healthcare...
F2 Strategy Acquires HBMJ Consulting to Expand Into Alternative Investments
F2 Strategy Acquires HBMJ Consulting to Expand Into Alternative Investments
Oct 15, 2025
Strategic move broadens platform capabilities, integrating hedge fund and alternative investments expertise into F2’s consulting model CHICAGO--(BUSINESS WIRE)-- F2 Strategy (“F2”), the leading business and digital transformation services firm to the global wealth and asset management industries, announced today it has acquired HBMJ Consulting LLC (“HBMJ”), a boutique consulting firm based in the New York City metro area. HBMJ...
MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio
MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio
Oct 15, 2025
Acquisition aims to strengthen company’s downstream process offering of advanced filtration and chromatography solutions JSR’s innovative Amsphere™ Protein A resin technology complements the company’s existing biologics portfolio Enhances the company’s capabilities to accelerate next-generation therapies by optimizing antibody purification BURLINGTON, Mass.--(BUSINESS WIRE)-- MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology...
Emmis Acquisition Corp.  Announces Upcoming Automatic Unit Separation
Emmis Acquisition Corp. Announces Upcoming Automatic Unit Separation
Oct 15, 2025
New York, NY, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Emmis Acquisition Corp. ( EMISU )  (the “Company”) announced today that, effective as of October 22, 2025, the Company’s units will no longer trade, and that the Company’s Class A ordinary shares and rights, which together comprise the units, will commence trading separately. The Class A ordinary shares and rights will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved